No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
C03xa01 |
- |
- |
- |
- |
2件: 67, 72 |
2 |
Desmopressin |
Desmopressin |
D00291, D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
5件: 6, 64, 72, 225, 288 |
3 |
Desmopressin intranasal |
Desmopressin |
D00291, D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
1件: 72 |
4 |
Desmopressin oral melt |
Desmopressin |
D00291, D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
1件: 72 |
5 |
Empagliflozin |
Empagliflozin |
D10459 |
- |
- |
2件: 72, 257 |
6 |
Empagliflozin 25mg |
Empagliflozin |
D10459 |
- |
- |
1件: 72 |
7 |
Empagliflozin 25mg tbl |
Empagliflozin |
D10459 |
- |
- |
1件: 72 |
8 |
Iupac |
- |
- |
- |
- |
1件: 72 |
9 |
Samsca |
Tolvaptan |
D01213 |
1件: AVPR2 |
3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
2件: 67, 72 |
10 |
Samsca*10cpr 15mg |
Tolvaptan |
D01213 |
1件: AVPR2 |
3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
1件: 72 |
11 |
Satavaptan |
Satavaptan |
- |
- |
- |
1件: 72 |
12 |
Satavaptan (sr121463b) |
Satavaptan |
- |
- |
- |
1件: 72 |
13 |
Sr121463b |
- |
- |
- |
- |
1件: 72 |
14 |
Tolvaptan |
Tolvaptan |
D01213 |
1件: AVPR2 |
3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
3件: 67, 72, 225 |
15 |
Tolvaptan in euvolemic hyponatremia |
Tolvaptan |
D01213 |
1件: AVPR2 |
3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
1件: 72 |
16 |
Tolvaptan oral tablet |
Tolvaptan |
D01213 |
1件: AVPR2 |
3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
1件: 72 |